Melbourne Clinical Trials
Mini Tablet Study
The purpose of this study is to test a potential new treatment for Wilson Disease. Wilson disease is an inherited disorder in which excessive amounts of copper accumulate in the body.
3 x 11 nights
1 visits
This treatment has already gone through multiple clinical studies. It has been tested in 108 healthy volunteers and 28 patients with Wilson Disease. In this study we want to compare how it is absorbed by the human body as a mini tablet compared to the regular tablet size. If approved, this new medication will offer a more efficient treatment option for this rare genetic disorder.
The trial has been approved by an independent ethics committee and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males or females
Age 18 - 55 years old
BMI 18 - 32 kg/m²
Weight 50 - 100 kg
Medications Not taking any (hormonal contraception allowed)
Medical History Nothing significant
Smoking History Non-smokers